Norwich NR592 2022 September Complete Course Latest (Full)

Question # 00641659
Course Code : NR592
Subject: Health Care
Due on: 11/16/2022
Posted On: 11/16/2022 04:56 AM
Tutorials: 1
Rating:
4.9/5
Question Dot Image

NR592 PMHNP - Population Focus Pharmacology

Week 1 Discussion

Your instructor will prime the discussion forum this week. Each discussion forum will indicate the student(s) assigned to that forum, as well as the unique question(s). Find the discussion forum you are assigned to and respond as a reply with your initial post to the thread. Then, reply to three other discussion forums. Although more than one student may be assigned to each forum, this should be completed as an individual assignment. (If you do not find your name assigned, email your instructor right away.)

 

NR592 PMHNP - Population Focus Pharmacology

Week 2 Discussion

Discuss how current nomenclature of psychotropic drugs can be misleading in our current context. What can we do to educate patients and communicate more accurately and clearly with patients?

 

NR592 PMHNP - Population Focus Pharmacology

Week 3 Discussion

New monoamine agonists: Choose one of the new monoamine agonists. Discuss risks and benefits of choosing one of these newer medications to treat your patients’ anxiety and depression. Why might you choose a newer one rather than an older one? Elaborate on a case where a newer agent might be helpful and why.

Dopamine blockers: Why is dopamine dosed differently for different conditions? Choose a diagnosis that you will likely treat as a provider and consider which dopamine blocker you might use and how you would dose that medication for the diagnosis chosen.

 

NR592 PMHNP - Population Focus Pharmacology

Week 4 Discussion

Second Messenger Modifier: Discuss the risks and benefits of lithium. Is lithium a dangerous or helpful medication? Describe a case where lithium might be used and possible outcomes.

Other Agents: Choose one of the ‘other agents’ presented and discuss why you might choose it over a more traditional medication. Does this choice offer risks or benefits to the patient?

 

NR592 PMHNP - Population Focus Pharmacology

Week 5 Discussion

Diagnostic Validators: What are the diagnostic validators? How are they at odds with the Diagnostic and Statistical Manual (DSM), the book typically used to define mental illness for insurance purposes? How might this potentially impact your daily practice?Affective Illness: Describe Major Depressive Illness. What is at least one other diagnosis that may be conflated or confused with this diagnosis and why?

NR592 PMHNP - Population Focus Pharmacology

Week 6 Discussion

Personality: What is a personality trait (‘disorder’)? Which medications treat personality most effectively? Often medication fails to treat personality. What are your options as a provider if this is the case? What would you do for a patient who does not respond to medication?

Addiction: Discuss pharmacologic choices for the treatment of addiction. Can addiction be treated with medication alone? What additional supports do you need as a provider to treat addiction effectively?

 

NR592 PMHNP - Population Focus Pharmacology

Week 7 Discussion

Seasonal Affective Illness: What is seasonal affective illness? What are medications as well as behavioral interventions that can be used to treat SAI? As a provider, would you plan to see a patient with SAI only at the times of year when they are affected by seasons?

Children: Choose one of the diagnoses identified in children and how it can be managed with medication, as well as if behavioral interventions are effective.

 

NR592 PMHNP - Population Focus Pharmacology

Week 8 Discussion

Older Persons: Choose one diagnosis in an older adult, identify the challenges that diagnosis presents with aging, and which medication may be used to treat it, as well as the advantages and disadvantages of this choice in an older person.

Women: Discuss the risks and benefits of the use of psychotropic medications during pregnancy. In practice, will you treat women during pregnancy and lactation? Why or why not?

 

NR592 PMHNP - Population Focus Pharmacology

Week 9 Discussion

Cultural Aspects: How does treatment of psychiatric conditions in America differ from other places in the world? Should this affect the way we practice? Can we learn from the way psychiatric conditions are managed elsewhere?

Treatment vs. Enhancement: Describe the dilemma of treatment vs. enhancement. How might this become challenging in caring for patients? As a provider, imagine a scenario where this dilemma could arise during every day practice.

Pharmaceutical Industry: What role does the pharmaceutical industry play in prescribing? Do pharmaceutical companies cause overprescribing and polypharmacy? What responsibility will you have as a provider in this situation?

 

NR592 PMHNP - Population Focus Pharmacology

Week 10 Discussion

Med Check: What is a med check? How can we use those visits effectively in practice? How long does a provider need to spend with a patient to have an effective visit in psychiatry?

Placebo Effect: What is the placebo effect? How can it be helpful in psychiatric practice? Do you have a responsibility to share with the patient if you feel they are experiencing a placebo rather than a therapeutic effect?

 

NR592 PMHNP - Population Focus Pharmacology

Week 11 Discussion

Describe how you would like to practice prescribing psychotropic medications. What type of prescriber will you be and why? Feel free to be idealistic; start to work on establishing a prescribing philosophy!

 

NR592 PMHNP - Population Focus Pharmacology

Week 3 Assignment

Choose a patient for Final Case Study Paper

Please read the three Case Studies for Final Paper and chose which one you would like to use for your final paper.

Case Study One - 22-year-old male

Case Study Two - 26-year-old female

Case Study Three - 27-year-old female

Your selection: Case Study Two - 26-year-old female

 

NR592 PMHNP - Population Focus Pharmacology

Week 10 Assignment

Final Case Study Project

Earlier in the course you chose one of the three following cases using the Week 03 Choose a patient for Final Case Study Paper:

Case Study One - 27-year-old male

Case Study Two - 26-year-old female

Case Study Three - 27-year-old female

By reading their case studies in Case Studies for Final Paper document.

Instructions:

For the patient you chose earlier, write a paper of 2-3 pages (using APA formatting and citations) discussing the following seven points based on the diagnosis given:

What medication do you choose?  Provide the name, dose, and prescription instructions.

If your patient is NOT currently taking a medication:

What class of medication are you choosing and why? 

Why you chose this med and not others. Include the pharmacodynamic action of the medication you are choosing versus the other options. 

Include either a research article or evidenced based guideline that supports your decision making and selection process.   Give rationale and reference your information. 

If your patient is already prescribed a medication:

Do you choose to continue the medication as currently prescribed?  Do you make changes to the current dose and/or instructions? Do choose to change the medication?

State your decision and answer the following questions:

(If you choose to change medications, state what medication you choose.  Provide the name, dose, and prescription instructions.)

What class of medication are you choosing (whether changing or staying with current med) and why? 

Why you chose this medication and not others. Include the pharmacodynamic action of the med you are choosing versus the other options. 

Include either a research article or evidenced based guideline that supports your decision making and selection process.   Give rationale and reference your information. 

List 3-5 instructional points you would include in educating the patient/family.

Note: There are probably many things you could include in your instruction but do not exceed 5 points. Select the most important points relative to this medication and this case.  Don’t just copy and paste into this section.  Make it meaningful to this patient.

What are the potential side effects and/or adverse drug reactions and how should they be managed?   What would you expect (common or nuisance) that your patient might experience, and what are your worst-case scenarios?  If these occur, what would you want your patient to do? Are there any monitoring considerations or tests you want to order? (Medication levels, blood tests, EKG, other screenings?)

What are potential drug interactions for THIS patient and what would your education and management be? (Note: This answer may be none.)  Don’t just copy and paste drug interactions into this area.  What is applicable for this patient? If the answer is none, can you think of potential concerns or what instructions would you provide to them?

How would you monitor the efficacy of this medication?  Specifically, when would you expect this medication to work?  When would you want to see this patient again?  How will you know it is working?  Are there lab tests or other information that you would need to gather to see if this medication is efficacious?

What are alternative treatment plans should this option fail?  Specifically address what medication, how and when you would use it.

How would this treatment change if the patient was pregnant?  Specifically, what risk category risk in pregnancy is this medication? How would you approach this medication with a pregnant patient?

Click on "Add Submission" and upload your paper below. "SAVE", and then "Submit for grading"

Your Instructor will be using the attached grading rubric. Note the different criteria in rubric before you submit.

NOTE: You will post your paper in the last week Discussion Forum and will be expected to choose one other paper from your same case study topic area to review and comment on. This will be a great time to reach out to see what other possibilities there are for treatment and for you and others to discuss those treatments in a constructive way. Did you or others miss something, which approach might be better, etc. Is there a way you can help others in your cohort about different methods of treatment?

 

 

 

NR592 PMHNP - Population Focus Pharmacology

Week 11 Final Case Study

To learn from others and to teach is the best education.

Last week you posted your Final Paper and now you and your classmates will discuss the papers to see how you could improve and if there are different methods that students employed around their particular case study.

Question(s):

Post your final paper to the discussion forum.

Pick one other student with the same case study as yours and compare and contrast your two (probably) different treatment methods for your patient.

If you have time to read other papers and comment, it is very helpful to have "team think" around treatments as complicated as these, What can you learn from others or insights can you offer?

Dot Image
Getsolution Posted By :
Questions: 15503 Tutorials: 15502
Tutorials for this Question

Norwich NR592 2022 September Complete Course Latest (Full)

Tutorial # 00640539
Posted On: 11/16/2022 04:57 AM
Feedback Score: Not rated yet!
Purchased By: 2
Getsolution
Posted By:
Questions:
15503
Tutorials:
15502
Report this Tutorial as Inappropriate
Tutorial Preview
The solution of Norwich NR592 2022 September Complete Course Latest (Full)...
Attachments
Norwich_NR592_2022_September_Complete_Course_Latest_(Full).ZIP (18.96 KB)

Great! We have found the solution of this question!

Related Questions
Norwich NR592 2022 September Week 11 Discussion Latest
NR592 PMHNP - Population Focus Pharmacology Week 11 Discussion Describe how you would like to practice prescribing psychotropic medications. What type of prescriber will you be and why? Feel fr …
Norwich NR592 2022 September Week 2 Discussion Latest
NR592 PMHNP - Population Focus Pharmacology Week 2 Discussion Discuss how current nomenclature of psychotropic drugs can be misleading in our current context. What can we do to educate patients …
Norwich NR592 2022 September Week 5 Discussion Latest
NR592 PMHNP - Population Focus Pharmacology Week 5 Discussion Diagnostic Validators: What are the diagnostic validators? How are they at odds with the Diagnostic and Statistical Manual (DSM), t …
Norwich NR592 2022 September Week 10 Discussion Latest
NR592 PMHNP - Population Focus Pharmacology Week 10 Discussion Med Check: What is a med check? How can we use those visits effectively in practice? How long does a provider need to spend with a …
Norwich NR592 2022 September Week 7 Discussion Latest
NR592 PMHNP - Population Focus Pharmacology Week 7 Discussion Seasonal Affective Illness: What is seasonal affective illness? What are medications as well as behavioral interventions that can b …
Norwich NR592 2022 September Week 8 Discussion Latest
NR592 PMHNP - Population Focus Pharmacology Week 8 Discussion Older Persons: Choose one diagnosis in an older adult, identify the challenges that diagnosis presents with aging, and which medica …
Norwich NR592 2022 September Week 4 Discussion Latest
NR592 PMHNP - Population Focus Pharmacology Week 4 Discussion Second Messenger Modifier: Discuss the risks and benefits of lithium. Is lithium a dangerous or helpful medication? Describe a case …
Norwich NR592 2022 September Week 6 Discussion Latest
NR592 PMHNP - Population Focus Pharmacology Week 6 Discussion Personality: What is a personality trait (‘disorder’)? Which medications treat personality most effectively? Often medi …
Norwich NR592 2022 September Week 1 Discussion Latest
NR592 PMHNP - Population Focus Pharmacology Week 1 Discussion Your instructor will prime the discussion forum this week. Each discussion forum will indicate the student(s) assigned to that foru …
Norwich NR592 2022 September Week 3 Discussion Latest
NR592 PMHNP - Population Focus Pharmacology Week 3 Discussion New monoamine agonists: Choose one of the new monoamine agonists. Discuss risks and benefits of choosing one of these newer medicat …
Recent Questions
Walden HLTH6475 Complete Course Latest 2024
HLTH6475 Prgm Plan, Implement & Eval Module 1 Discussion INDIVIDUAL RESPONSIBILITY VERSUS VICTIM BLAMING IN HEALTH PROMOTION Part of what makes a discussion a discussion and not a lectur …
Walden HLTH6475 All Quizzes Latest 2024
HLTH6475 Prgm Plan, Implement & Eval Module 1 Quiz Question 1 Which factors have been found to influence behavior? Socioeconomic Status Skills Culture Attitude Gender A …
Walden HLTH6475 Module 6 Quiz Latest 2024
HLTH6475 Prgm Plan, Implement & Eval Module 6 Quiz Question 1 Which method allows study participants to tell their stories?  Observations In-depth individual interview &nbs …
Walden HLTH6475 Module 5 Quiz Latest 2024
HLTH6475 Prgm Plan, Implement & Eval Module 5 Quiz Question 1 What alternative term has been suggested recently for hard-to-reach? Marginalized Inaccessible Hard to access Ha …
Walden HLTH6475 Module 4 Quiz Latest 2024
HLTH6475 Prgm Plan, Implement & Eval Module 4 Quiz Question 1 Outreach workers from the CeaseFire program spent a total of 500 combined hours with program participants during the first y …
Walden HLTH6475 Module 3 Quiz Latest 2024
HLTH6475 Prgm Plan, Implement & Eval Module 3 Quiz Question 1 Which of the following is the construct of the Theory of Reasoned Action that explains behavior based on what we think other …
Walden HLTH6475 Module 2 Quiz Latest 2024
HLTH6475 Prgm Plan, Implement & Eval Module 2 Quiz Question 1 If the program is aimed at a true population, the term is called ______________. Intended population Intended audience …
Walden HLTH6475 All Assignments Latest 2024
HLTH6475 Prgm Plan, Implement & Eval Module 2 Assignment LANNING MODELS ARTICLE REVIEW The published literature is rich with examples of health promotion programs that have utilized the …
Walden HLTH6475 Module 6 Assignment Latest 2024
HLTH6475 Prgm Plan, Implement & Eval Module 6 Assignment EVALUATION PLAN Once the program has been designed, it is time to consider how the program will be evaluated. To design an evalu …
Walden HLTH6475 Module 5 Assignment Latest 2024
HLTH6475 Prgm Plan, Implement & Eval Module 5 Assignment  DEVELOPING EVALUATION QUESTIONS Evaluation takes place at various points within a program's life cycle. It requires di …